H7N9 Influenza Virus in China

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2020 Mar 25

PMID 32205415

Citations 42

Authors

Chengjun Li

Hualan Chen

Affiliations

Soon will be listed here.

Abstract

In early 2013, human infections caused by a novel H7N9 avian influenza virus (AIV) were first reported in China; these infections caused severe disease and death. The virus was initially low pathogenic to poultry, enabling it to spread widely in different provinces, especially in live poultry markets. Importantly, the H7N9 low pathogenic AIVs (LPAIVs) evolved into highly pathogenic AIVs (HPAIVs) in the beginning of 2017, causing a greater threat to human health and devastating losses to the poultry industry. Fortunately, nationwide vaccination of chickens with an H5/H7 bivalent inactivated avian influenza vaccine since September 2017 has successfully controlled H7N9 avian influenza infections in poultry and, importantly, has also prevented human infections. In this review, we summarize the biological properties of the H7N9 viruses, specifically their genetic evolution, adaptation, pathogenesis, receptor binding, transmission, drug resistance, and antigenic variation, as well as the prevention and control measures. The information obtained from investigating and managing the H7N9 viruses could improve our ability to understand other novel AIVs and formulate effective measures to control their threat to humans and animals.

Citing Articles

Emergence of a novel reassortant H3N3 avian influenza virus with enhanced pathogenicity and transmissibility in chickens in China.

Zhang C, Zhao C, Huang J, Wang Y, Jiang B, Zheng H Vet Res. 2025; 56(1):56.

PMID: 40069883 PMC: 11899391. DOI: 10.1186/s13567-025-01484-1.

Genome-wide siRNA library screening identifies human host factors that influence the replication of the highly pathogenic H5N1 influenza virus.

Wang G, Jiang L, Wang J, Li Q, Zhang J, Kong F mLife. 2025; 4(1):55-69.

PMID: 40026577 PMC: 11868839. DOI: 10.1002/mlf2.12168.

Molecular patterns of matrix protein 1 (M1): A strong predictor of adaptive evolution in H9N2 avian influenza viruses.

Zhu Y, Cong Y, Sun Y, Sheng S, Liu C, Jiang J Proc Natl Acad Sci U S A. 2025; 122(9):e2423983122.

PMID: 40020189 PMC: 11892622. DOI: 10.1073/pnas.2423983122.

Isoleucine at position 137 of haemagglutinin acts as a mammalian adaptation marker of H9N2 avian influenza virus.

Ma W, Ren C, Shi L, Meng B, Feng Y, Zhang Y Emerg Microbes Infect. 2025; 14(1):2455597.

PMID: 39817459 PMC: 11789229. DOI: 10.1080/22221751.2025.2455597.

The novel H10N3 avian influenza virus acquired airborne transmission among chickens: an increasing threat to public health.

Wang X, Yu H, Ma Y, Zhang P, Wang X, Liang J mBio. 2024; 16(2):e0236324.

PMID: 39679681 PMC: 11796378. DOI: 10.1128/mbio.02363-24.

References

Zhu H, Lam T, Smith D, Guan Y . Emergence and development of H7N9 influenza viruses in China. Curr Opin Virol. 2016; 16:106-113. DOI: 10.1016/j.coviro.2016.01.020. View

Zhu W, Li L, Yan Z, Gan T, Li L, Chen R . Dual E627K and D701N mutations in the PB2 protein of A(H7N9) influenza virus increased its virulence in mammalian models. Sci Rep. 2015; 5:14170. PMC: 4585756. DOI: 10.1038/srep14170. View

Tharakaraman K, Jayaraman A, Raman R, Viswanathan K, Stebbins N, Johnson D . Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell. 2013; 153(7):1486-93. PMC: 3746546. DOI: 10.1016/j.cell.2013.05.034. View

Zhang Y, Zhang Q, Kong H, Jiang Y, Gao Y, Deng G . H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet. Science. 2013; 340(6139):1459-63. DOI: 10.1126/science.1229455. View

Neumann G, Macken C, Kawaoka Y . Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J Virol. 2014; 88(9):4877-96. PMC: 3993844. DOI: 10.1128/JVI.00107-14. View

Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W . Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368(20):1888-97. DOI: 10.1056/NEJMoa1304459. View

Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J . Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology. 2005; 341(1):153-62. DOI: 10.1016/j.virol.2005.07.011. View

Pantin-Jackwood M, Miller P, Spackman E, Swayne D, Susta L, Costa-Hurtado M . Role of poultry in the spread of novel H7N9 influenza virus in China. J Virol. 2014; 88(10):5381-90. PMC: 4019135. DOI: 10.1128/JVI.03689-13. View

Chen G, Kuo S, Yang S, Gong Y, Hsiao M, Liu Y . Genomic Signatures for Avian H7N9 Viruses Adapting to Humans. PLoS One. 2016; 11(2):e0148432. PMC: 4742285. DOI: 10.1371/journal.pone.0148432. View

10.

Pu Z, Xiang D, Li X, Luo T, Shen X, Murphy R . Potential Pandemic of H7N9 Avian Influenza A Virus in Human. Front Cell Infect Microbiol. 2018; 8:414. PMC: 6265602. DOI: 10.3389/fcimb.2018.00414. View

11.

Su S, Gu M, Liu D, Cui J, Gao G, Zhou J . Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China. Trends Microbiol. 2017; 25(9):713-728. DOI: 10.1016/j.tim.2017.06.008. View

12.

Wu J, Ke C, Lau E, Song Y, Cheng K, Zou L . Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017-18. Emerg Infect Dis. 2018; 25(1):116-118. PMC: 6302570. DOI: 10.3201/eid2501.181259. View

13.

Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva L . R292K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerg Infect Dis. 2013; 19(9):1521-4. PMC: 3810934. DOI: 10.3201/eid1909.130724. View

14.

Li C, Bu Z, Chen H . Avian influenza vaccines against H5N1 'bird flu'. Trends Biotechnol. 2014; 32(3):147-56. DOI: 10.1016/j.tibtech.2014.01.001. View

15.

Qi W, Jia W, Liu D, Li J, Bi Y, Xie S . Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor. J Virol. 2017; 92(2). PMC: 5752946. DOI: 10.1128/JVI.00921-17. View

16.

Marjuki H, Mishin V, Chesnokov A, De La Cruz J, Davis C, Villanueva J . Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses. J Virol. 2015; 89(10):5419-26. PMC: 4442539. DOI: 10.1128/JVI.03513-14. View

17.

Yamayoshi S, Kiso M, Yasuhara A, Ito M, Shu Y, Kawaoka Y . Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans. Emerg Infect Dis. 2018; 24(4):746-750. PMC: 5875272. DOI: 10.3201/eid2404.171509. View

18.

Shi Y, Zhang W, Wang F, Qi J, Wu Y, Song H . Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science. 2013; 342(6155):243-7. DOI: 10.1126/science.1242917. View

19.

Liang L, Jiang L, Li J, Zhao Q, Wang J, He X . Low Polymerase Activity Attributed to PA Drives the Acquisition of the PB2 E627K Mutation of H7N9 Avian Influenza Virus in Mammals. mBio. 2019; 10(3). PMC: 6581862. DOI: 10.1128/mBio.01162-19. View

20.

Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J . Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013; 381(9881):1916-25. PMC: 7134567. DOI: 10.1016/S0140-6736(13)60903-4. View